Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients

(2015) Christof Vulsteke et al.   BREAST CANCER RESEARCH AND TREATMENT

A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer

(2015) Folefac Aminkeng et al.   NATURE GENETICS

Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20+ B-cell lymphoma

(2015) Annegret Reichwagen et al.   PHARMACOGENOMICS

Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children

(2015) Henk Visscher et al.   PHARMACOGENOMICS

Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia

(2015) M Krajinovic et al.   PHARMACOGENOMICS JOURNAL

Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions

(2014) Ursula Amstutz et al.   EPILEPSIA

Hyaluronan Synthase 3 Variant and Anthracycline-Related Cardiomyopathy: A Report From the Children's Oncology Group

(2014) Xuexia Wang et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography

(2014) A. Blythe Ryerson et al.   PEDIATRIC BLOOD & CANCER

Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia

(2013) Steven E. Lipshultz et al.   CANCER

Educational Paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician

(2013) Rejane F. Dillenburg et al.   EUROPEAN JOURNAL OF PEDIATRICS

Association of Anthracycline-Related Cardiac Histological Lesions With NADPH Oxidase Functional Polymorphisms

(2013) A. Cascales et al.   ONCOLOGIST

Validation of variants inSLC28A3andUGT1A6as genetic markers predictive of anthracycline-induced cardiotoxicity in children

(2013) H. Visscher et al.   PEDIATRIC BLOOD & CANCER

Retinoid signaling in control of progenitor cell differentiation during mouse development

(2013) Gregg Duester   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor

(2013) Joanna M. Lubieniecka et al.   Frontiers in Genetics

Single-Nucleotide Polymorphisms in Aldo-Keto and Carbonyl Reductase Genes Are Not Associated with Acute Cardiotoxicity after Daunorubicin Chemotherapy

(2012) J. M. Lubieniecka et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

RAR  is essential for retinoic acid induced chromatin remodeling and transcriptional activation in embryonic stem cells

(2012) V. Kashyap et al.   JOURNAL OF CELL SCIENCE

The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms

(2012) Bilge Volkan Salanci et al.   JOURNAL OF CHEMOTHERAPY

Retinoic Acid Signalling Is Activated in the Postischemic Heart and May Influence Remodelling

(2012) Dusan Bilbija et al.   PLoS One

Unexpected doxorubicin-mediated cardiotoxicity in sisters: Possible role of polymorphisms in histamine n-methyl transferase

(2012) Kamakshi Sachidanandam et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Guide to Receptors and Channels (GRAC), 5th edition

(2011) SPH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma

(2011) Rachael E. Windsor et al.   CANCER

ABCC1polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia

(2011) Agnes F. Semsei et al.   CELL BIOLOGY INTERNATIONAL

Retinoic Acid Production by Endocardium and Epicardium Is an Injury Response Essential for Zebrafish Heart Regeneration

(2011) Kazu Kikuchi et al.   DEVELOPMENTAL CELL

Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children

(2011) Henk Visscher et al.   JOURNAL OF CLINICAL ONCOLOGY

Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group

(2011) Javier G. Blanco et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical and genetic determinants of anthracycline-induced cardiac iron accumulation

(2010) Almudena Cascales et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer

(2010) Markhaba Tukenova et al.   JOURNAL OF CLINICAL ONCOLOGY

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Genetics and Beyond – The Transcriptome of Human Monocytes and Disease Susceptibility

(2010) Tanja Zeller et al.   PLoS One

New Developments in Anthracycline-Induced Cardiotoxicity

(2009) A. Mordente et al.   CURRENT MEDICINAL CHEMISTRY

Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21

(2009) D Rossi et al.   LEUKEMIA

Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood

(2009) Vladan Rajić et al.   LEUKEMIA & LYMPHOMA

Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer

(2008) Javier G. Blanco et al.   CANCER

Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane

(2008) Elly V. Barry et al.   JOURNAL OF CLINICAL ONCOLOGY

Monitoring of Anthracycline-Induced Cardiotoxicity

(2007) Abigail Jannazzo et al.   ANNALS OF PHARMACOTHERAPY